Problems in Qualitative Gas-Chromatographic Analysis of Steriods on Open-Hole Capillary Columns

Total Page:16

File Type:pdf, Size:1020Kb

Problems in Qualitative Gas-Chromatographic Analysis of Steriods on Open-Hole Capillary Columns Problems in qualitative gas-chromatographic analysis of steriods on open-hole capillary columns Citation for published version (APA): Groenendijk, H. (1970). Problems in qualitative gas-chromatographic analysis of steriods on open-hole capillary columns. Technische Hogeschool Eindhoven. https://doi.org/10.6100/IR123356 DOI: 10.6100/IR123356 Document status and date: Published: 01/01/1970 Document Version: Publisher’s PDF, also known as Version of Record (includes final page, issue and volume numbers) Please check the document version of this publication: • A submitted manuscript is the version of the article upon submission and before peer-review. There can be important differences between the submitted version and the official published version of record. People interested in the research are advised to contact the author for the final version of the publication, or visit the DOI to the publisher's website. • The final author version and the galley proof are versions of the publication after peer review. • The final published version features the final layout of the paper including the volume, issue and page numbers. Link to publication General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal. If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above, please follow below link for the End User Agreement: www.tue.nl/taverne Take down policy If you believe that this document breaches copyright please contact us at: [email protected] providing details and we will investigate your claim. Download date: 04. Oct. 2021 .. PROBLEMS IN QUALITATIVE GAS­ CHROMATOGRAPHIC ANALYSIS OF STEROIDS ON OPEN-HOLE CAPILLARY COLUMNS PROEFSCHRIFT TER VERKRIJGING VAN DE GRAAD VAN DOCTOR IN DE TECHNISCHE WETENSCHAPPEN AAN DE TECHNISCHE HOGESCHOOL TE EINDHOVEN OP GEZAG VAN DE RECTOR MAGNIFICUS PROF. DR. IR. A. A. TH. M. VAN TRIER, HOOGLERAAR IN DE AFDELING DER ELEKTROTECHNIEK, VOOR EEN COMMISSIE UIT DE SENAAT TE VERDEDIGEN OP VRIJDAG 18 DECEMBER 1970 DES NAMIDDAGS TE 4 UUR DOOR HUlBERT GROENENDIJK GEBOREN TE MELISSANT DIT PROEFSCHRIFT IS GOEDGEKEURD DOOR DE PROMOTOR PROF. DR. IR. A. I. M. KEULEMANS Aan mijn vrouw Aan Richard en Natasha \ ? CONTENTS I. INTRODUCTION . 1.1. General . t .2. Gas chromatography 3 1.2.1. Basic concepts 3 1.2.2. Retention time 4 1.2.3. Relative retention 5 1.2.4. Plate theory 6 1.2.5. Rate theory 6 1.2.6. Resolution 8 1.2.7. Effect of temperature on retention time 9 1.2.8. Selectivity of stationary phases 11 1.3. Steroids . 12 1.3.1. Steroid classes . 13 1.3.2. Stereoisomerism 13 1.3.3. Nomenclature 15 References . 17 2. CHROMATOGRAPHIC ANALYSIS OF STEROIDS 18 2.1. Introduction . 18 2.2. Biological significance . 20 2.3. Conventional methods of steroid analysis 21 2.4. Pretreatment for gas-chromatographic steroid analysis . 22 2.4.1. Steroid conjugates 22 2.4.2. Hydrolysis 24 2.4.3. Extraction . 26 2.4.4. Sample preparation 26 2.4.5. The sample pretreatment adopted 27 2.5. Gas-chromatographic steroid analysis 28 2.5.1. Type of column .... 29 2.5.2. Column support 30 2.5.3. Liquid (stationary) phase 31 2.5.4. Preparation of columns 33 2.6. Steroid derivatives 34 2.7. Detection systems 38 References . 39 3. OPEN-HOLE CAPILLARY COLUMNS IN GAS-CHROMATO- GRAPHIC STEROID ANALYSIS 42 3.1. Introduction . 42 3.2. The gas-chromatographic system 43 3.3. Column material . 45 3.4. Factors determining the choice of column diameter and length . 45 3.4.1. Column efficiency . 45 3.4.2. Analysis time . 46 3.4.3. Pressure drop 47 3.4.4. Sample capacity 47 3.4.5. Linear carrier-gas velocity 48 3.4.6. Resolution . 48 3.4.7. Detection limit 48 3.4.8. Conclusion 48 3.5. Stationary phases . 49 3.5.1. Non-selective phases 49 3.5.2. Selective phases 53 3.5.3. Volatility 57 3.5.4. Stability . 59 3.6. Column preparation. 62 3.6.1. Column cleaning 62 3.6.2. Static coating method 62 3.6.3. Dynamic coating method 62 3.6.4. Modified static coating method 63 3.6.5. Column conditioning . 63 3.7. Comparison of packed and open-hole tubular columns. 64 3.7.1. The volumetric phase ratio 64 3.7.2. Column permeability . 65 3.7.3. Resolution . 65 3. 7.4. Number of theoretical plates required 67 3.7.5. Detection limit 73 3.8. Natural samples 73 References . 77 4. CARBON NUMBER, A NEW DEFINITION 78 4.1. Introduction . 78 4.2. Determination of column hold-up time 80 4.2.1. Direct measurement of t M 81 4.2.2. Indirect measurement of tM 81 4.2.3. Calculation of (v . 82 4.3. Linearity of the log plot 86 4.3.1. Testing the linearity of the log plot 86 4.3.2. Linearity of the C18-C32 region 86 4.3.3. Linearity of the CcC9 region 89 4.4. Carbon Index, a new concept . 98 4.4.1. Definition of the standards 98 4.4.2. Definition of the carbon index . 98 4.4.3. Equivalent definitions of the carbon index 100 4.5. Computer program 101 References 104 5. IDENTIFICATION 105 5.1. Introduction . 105 5.2. General identification parameters 107 5.2.1. Isothermal relative retention parameters 107 5.2.2. Programmed-temperature retention parameters 108 5.2.3. Boiling-point index . 109 5.2.4. Other identification parameters . 109 5.3. Parameters used for the identification of steroids . 109 5.3.1. Definition of steroid-identification parameters 110 5.3.2. Comparison of reference sets . 112 5.4. Temperature dependence of retention parameters 117 5.4.1. Temperature-retention-time relationships . 117 5.4.2. Plea for a new identification parameter 120 5.5. Molecular-structure-retention-behaviour relationships 121 5.5.1. Survey of the literature . 123 5.5.2. Structure-retention relationships for the carbon index. 126 5.6. Computer program IDENTIFICATION 129 5.6.1. Reliability of identification 130 5.6.2. Reference carbon indices 132 5.6.3. Procedure 132 References 134 6. DIRECT INJECTION INTO CAPILLARY COLUMNS 136 6.1. Introduction . 136 6.2. Direct injection of liquid samples 137 6.2.1. Direct injection without a cold zone 137 6.2.2. Direct injection with a cold zone . 140 6.3. Direct injection ofliquid samples with solvent elimination 143 6.4. Direct injection of solid samples . 146 6.5. Quantitative evaluation of the injection devices 153 6.5.1. Removal of the solvent . 153 6.5.2. Trap efficiency . 154 6.5.3. Influence on retention quantities 155 6.5.4. Contribution to peak-broadening 157 References . 161 Summary 163 Samenvatting. 165 Dankbetuiging 167 Levensbericht . 168 1- 1. INTRODUCTION 1.1. General Gas-chromatographic (GC) steroid analysis has grown rapidly since the early 1 1 investigations reported by Eglinton et al. in 1959 - ). Although the retention times in this work were very long, gas chromatography had proved its usefulness in the separation of compounds of low volatility and since that time steroid analysis in the vapour phase has become common practice. Today, the number of publications on the analysis of steroids, steroid hormones and sterols, both as pure compounds and in fairly complex mixtures, is quite considerable. One of the most interesting applications is steroid analysis in body fluids, which is extremely important for clinical purposes. Although steroids in body fluids constitute mixtures of fair complexity, in which steroids are present in a scale of concentrations together with numerous other compounds of biological origin, only packed columns have been used up till now. The lack of interest in the high resolving power of capillary columns as compared to packed columns may be due basically to some practical problems inherent in operating capillary columns at "high" temperatures. These practical problems chiefly concern the: Preparation of efficient columns The preparation of efficient columns appeared to constitute a considerable problem. It is very difficult to prepare columns that possess sufficient efficiency at the elevated temperatures required for gas-chromatographic steroid analysis. In particular, the preparation of columns with selective phases appeared to be cumbersome and once a good column was obtained, it degraded fairly quickly, resulting in a short column lifetime. This is mainly due to the lack of surface active agents stable at these high temperatures. Sample requirements The sample requirements of open-hole capillary columns present another practical problem. Apart from the limitation imposed on the construction of an injection device, the small amounts of material involved in GC analysis on capillary columns exclude the possibility of an additional identification. Samples can hardly be collected from the effluents of a capillary column. More­ over, established techniques such as u.v. and i.r. analysis of column effluents are not accessible to capillary columns. The only additional identification tool capable of handling the small sample sizes eluting from a capillary column is a gas-chromatograph- mass-spectrometer combination. Apart from practical problems involving the coupling between the gas chromatograph aud the mass spectrometer, the latter instrument is still fairly expensive.
Recommended publications
  • University Microfilms, Inc., Ann Arbor, Michigan ADRENOCORTICAL STEROID PROFILE IN
    This dissertation has been Mic 61-2820 microfilmed exactly as received BESCH, Paige Keith. ADRENOCORTICAL STEROID PROFILE IN THE HYPERTENSIVE DOG. The Ohio State University, Ph.D., 1961 Chemistry, biological University Microfilms, Inc., Ann Arbor, Michigan ADRENOCORTICAL STEROID PROFILE IN THE HYPERTENSIVE DOG DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of the Ohio State University By Paige Keith Besch, B. S., M. S. The Ohio State University 1961 Approved by Katharine A. Brownell Department of Physiology DEDICATION This work is dedicated to my wife, Dr. Norma F. Besch. After having completed her graduate training, she was once again subjected to almost social isolation by the number of hours I spent away from home. It is with sincerest appreciation for her continual encouragement that I dedi­ cate this to her. ACKNOWLEDGMENTS I wish to acknowledge the assistance and encourage­ ment of my Professor, Doctor Katharine A. Brownell. Equally important to the development of this project are the experience and information obtained through the association with Doctor Frank A. Hartman, who over the years has, along with Doctor Brownell, devoted his life to the development of many of the techniques used in this study. It is also with extreme sincerity that I wish to ac­ knowledge the assistance of Mr. David J. Watson. He has never complained when asked to work long hours at night or weekends. Our association has been a fruitful one. I also wish to acknowledge the encouragement of my former Professor, employer and good friend, Doctor Joseph W.
    [Show full text]
  • The Metabolism of Desmosterol in Human Subjects During Triparanol Administration
    THE METABOLISM OF DESMOSTEROL IN HUMAN SUBJECTS DURING TRIPARANOL ADMINISTRATION DeWitt S. Goodman, … , Joel Avigan, Hildegard Wilson J Clin Invest. 1962;41(5):962-971. https://doi.org/10.1172/JCI104575. Research Article Find the latest version: https://jci.me/104575/pdf Journal of Clinical Investigation Vol. 41, No. 5, 1962 THE METABOLISM OF DESMOSTEROL IN HUMAN SUBJECTS DURING TRIPARANOL ADMINISTRATION * BY DEWITT S. GOODMAN, JOEL AVIGAN AND HILDEGARD WILSON (From the Section on Metabolism, National Heart Institute, and the National Institute of Arthritis and Metabolic Diseases, Bethesda, Md.) (Submitted for publication October 25, 1961; accepted January 25, 1962) Recent studies with triparanol (1-[p-,3-diethyl- Patient G.B. was a 55 year old man with known arterio- aminoethoxyphenyl ]-1- (p-tolyl) -2- (p-chloro- sclerotic heart disease and mild hypercholesterolemia; phenyl)ethanol) have demonstrated that this com- since 1957 he had maintained a satisfactory and stable cardiac status. At the time of the present study he had pound inhibits cholesterol biosynthesis by blocking been taking 250 mg triparanol daily for 4 weeks, and had the reduction of 24-dehydrocholesterol (desmos- a total serum sterol level in the high normal range. terol) to cholesterol (2-4). Administration of Patient F.A. was a 40 year old man with a 4- to 5-year triparanol to laboratory animals and to man re- history of gout and essential hyperlipemia. At the time sults in of of this study he had been on an isocaloric low purine diet the accumulation desmosterol in the for several weeks, and both the gout and hyperlipemia plasma and tissues, usually with some concom- were in remission.
    [Show full text]
  • ラッ ト肝 の Steroid 5Β-Reductase 活性 に 対す る酢酸第 二水銀
    〔614〕 ラ ッ ト肝 の steroid 5β-reductase 活 性 に 対 す る酢 酸 第 二 水 銀 の 影 響 The Effect of Mercuric Acetate on the Activity of Steroid 5β-reductase in the Rat Liver 北海道大学医学部衛生学教室 富 田 勤 ・佐 藤 敏 雄 ・高 桑 栄 松 北海道大学大学院環境科学研究科環境医学教室 斎 藤 和 雄 Tsutomu Tomita, Toshio Sato and Eimatsu Takakuwa Department of Hygiene and Preventive Medicine, Hokkaido University School of Medicine, Sapporo Kazuo Saito Department of Environmental Medicine, Graduate School of Environmental Science, Hokkaido University, Sapporo The increase of urinary δ-aminolevulinic acid in man and animals exposed to high concentration of mercury is studied, but the mechanism of the increase has not been clearly explained. In this paper, the content of 5β type steroid, inducing δ-aminolevulinic acid synthetase, was studied by noticing the activities of steroid 5β-reductase, which is the rate limiting enzyme in metabolism of steroid hormones, 3α- and 3β-hydroxysteroid dehydrogenase. For measurement of these activities, 105,000×g supernatant of rat liver was used. The testosterone and ⊿4-androstene-3, 17-dione 5β-reductase activities decreased on either the fourth or eleventh day after either intraperitoneal or subcutaneous administration of mercuric acetate, respe- ctively, and the adrenosterone 5β-reductase activity increased on the eleventh day after the subcutaneous administration of mercuric acetate. These changes mentioned above, however, were not significant. The progesterone and 17α-hydroxy progesterone 5β-reductase activities decreased on either the fourth or eleventh day after either intraperitioneal or subcutaneous administration of mercuric acetate, but there were no significant changes.
    [Show full text]
  • United States Patent Office Patented Jan
    3,164,611 United States Patent Office Patented Jan. 5, 1965 1. 2 reaction, care must be taken in applying this method 3,164,611 to the oxidation of heat sensitive compounds. OXDATION OF PRIMARY AND SECONDARY AL COHOLS TO THE CORRESPONDING CARBONY These organic base-chromium trioxide complexes are CSCMPOUNDS (USNG A TERTARY AMENE particularly useful oxidizing agents for effecting the oxida (CERORySSJR, TROXDE COMPLEX tion of alcohols having at least one hydrogen atom at Lewis H. Sarett, Friscetos, N.J., assigaor to Merck & Co., tached to the carbon atom bearing the hydroxyl sub Inc., Rahway, N.J., a corporatioia of New Jersey Stituent, i.e., primary and secondary alcohols, to the No Drawing. Fied any 26, 1956, Ser. No. 686,463 corresponding carbonyl compounds. Thus, primary al 13 Caias. (C. 260-349.9) cohols are oxidized to aldehydes, and secondary alcohols IO are converted to ketones. This invention relates to a novel process for the oxida This method of oxidizing alcohols to the corresponding tion of chemical compounds, and more particularly to carbonyl compounds is generally applicable to all pri an improved method for the oxidation of primary and mary and secondary alcohols. Examples of such al Secondary alcohols to the corresponding carbonyl com cohols that might be mentioned are aliphatic alcohols pounds. 5 such as alkanals, alkenols, alkinois, polyhydric alkanols, This application is a continuation-in-part application polyhydric alkenols and polyhydric alkinols; aralkyl al of my application Serial No. 263,016, filed December cohols; aralkenyl alcohols; aralkinyl alcohols; alicyclic 22, 1951, now abandoned, and my copending application alcohols such as cycloalkyl, cycloalkenyl, cycloalkinyl, Serial No.
    [Show full text]
  • Characterization of Steroid-17,20-Desmolase and 20Α- Hydroxysteroid Dehydrogenase from Clostridium Scindens
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 1989 CHARACTERIZATION OF STEROID-17,20-DESMOLASE AND 20α- HYDROXYSTEROID DEHYDROGENASE FROM CLOSTRIDIUM SCINDENS Amy Elizabeth Krafft Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Microbiology Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/4980 This Dissertation is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. School of Basic Health Sciences Virginia Commonwealth University This is to certify that the thesis or dissertation prepared by Amy Elizabeth Krafft entitled "The Characterization of steroid-17,20-Desmolase and 20«­ Hydroxysteroid Dehydrogenase from Clostridium scindens" has been approved by her committee as satisfactory completion of the thesis or dissertation requirement for the degree of Doctor of Philosophy. CHARACTERIZATION OF STEROID-17,20-DESMOLASE AND 20a-HYDROTfSTEROID DEfffDROGENASE FROM CLOSTRIDITJM SCINDENS A thesis submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy at Virginia Commonwealth University By Amy Elizabeth Krafft B.S., Mary Washington College, 1977 Director: Dr. Phillip B. Hylemon, Professor, Department of Microbiology and Immunology Virginia Commonwealth University Richmond, Virginia May, 1989 ii Acknowledgements I wish to thank Dr . Phillip Hylemon for all of the support he has given me during my graduate training. I also would like to thank my committee members for their guidance: Drs . Francis Macrina, Darrell Peterson, Thomas Huff, and Charles Schwartz .
    [Show full text]
  • TEXAS RACING COMMISSION January 28, 2021 To
    TEXAS RACING COMMISSION P. O. Box 12080, Austin, Texas 78711-2080 8505 Cross Park Drive, Suite 110, Austin, Texas 78754-4552 Phone (512) 833-6699 Fax (512) 833-6907 www.txrc.texas.gov January 28, 2021 To: Stewards, Commission Veterinarians, Test Barn Supervisors, Practicing Veterinarians, Owners, and Trainers From: Chuck Trout, Executive Director Re: Effective February 25, 2021 changes to the following documents: • Permissible Levels of Therapeutic Medications and Naturally Occurring Substances • Equine Medication Classification Policy and Penalty Guidelines • Equine Medication Classification List. This memo is to provide notice that the above listed documents are to be replaced effective this date. The changes include, but are not limited to: • Changes to the list of Permissible Levels of Therapeutic Medications and Naturally Occurring Substances; • Changes to the Equine Medication Classification Policy and Penalty Guidelines; • Changes to the Equine Medication Classification List. These documents are subject to further revision at any time. Test Barn Supervisors - please post this memo and the revised documents in the test barn as soon as possible. Also, please distribute copies of the Permissible Levels of Therapeutic Medications and Naturally Occurring Substances and Equine Medication Classification List to the practicing veterinarians at your racetrack. Licensing Staff - please post this memo and the revised documents where they may be viewed by the public as soon as possible. Copies of these documents will be made available on the Commission's website at http://www.txrc.texas.gov. Attachments: Permissible Levels of Therapeutic Medications and Naturally Occurring Substances Equine Medication Classification Policy and Penalty Guidelines Equine Medication Classification List TEXAS RACING COMMISSION P.
    [Show full text]
  • A Histochemical Identification of the Cellular Sites of Androgen Synthesis in the Hypertrophied Right Gonad of the Leghorn Poulard
    Loyola University Chicago Loyola eCommons Dissertations Theses and Dissertations 1964 A Histochemical Identification of the Cellular Sites of Androgen Synthesis in the Hypertrophied Right Gonad of the Leghorn Poulard James Edward Woods Loyola University Chicago Follow this and additional works at: https://ecommons.luc.edu/luc_diss Part of the Anatomy Commons Recommended Citation Woods, James Edward, "A Histochemical Identification of the Cellular Sites of Androgen Synthesis in the Hypertrophied Right Gonad of the Leghorn Poulard" (1964). Dissertations. 738. https://ecommons.luc.edu/luc_diss/738 This Dissertation is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It has been accepted for inclusion in Dissertations by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. Copyright © 1964 James Edward Woods A HISTOCHEMICAL IDENTIFICATION OF me CELLULAR SITES OF ANDROGEN SYNTltESIS IN THE HYPERTROPHIED RIGUT GONAD OF THE LEGHORN POULAJU) a\\CH SCHO "-." 0 C!) LOYOLA (' UNIVERSITY Of: MED\C\~~ by J..... Edward Wood. A Dissertation SUbaitted to tbe Faculty of tbe Graduate School of Loyola University 1n Partial Fulfillment of the Require.-nts for the Degree of Doctor of Philosophy June 1964 ACKNOWLEDGEMENTS I wish to express ~ sincere appreciation to Dr. Lincoln V. Ooma for suggesting the probl_, indoctrination into the vagaries of sex. biology and for his patience throughout the exteaded period of this investiaation. To Or. Leslie A. emaert for many iDterestlng discussions on the historical aspects of lipid histochemistry and for advice and counsel on a mul. titude of aatters pertaining to the dissertation go my heartfelt thanks.
    [Show full text]
  • STUDIES in STEROID METABOLISM. XIX. the A-KETOSTEROID EXCRETION PATTERN in NORMAL MALES
    STUDIES IN STEROID METABOLISM. XIX. THE a-KETOSTEROID EXCRETION PATTERN IN NORMAL MALES Konrad Dobriner, … , C. P. Rhoads, T. F. Gallagher J Clin Invest. 1953;32(10):940-949. https://doi.org/10.1172/JCI102819. Research Article Find the latest version: https://jci.me/102819/pdf STUDIES IN STEROID METABOLISM. XIX. THE a-KETOSTEROID EXCRETION PATTERN IN NORMAL MALES ' By KONRAD DOBRINER 2 THE DATA WERE ASSEMBLED AND THE MANUSCRIPT PREPARED BY:8 ATTALLAH KAPPAS,4 C. P. RHOADS AND T. F. GALLAGHER (From the Laboratories of the Sloan-Kettering Institute for Cancer Research, New York, New York) (Submitted for publication April 6, 1953; accepted May 29, 1953) The urinary steroids afford a means for evalua- for periods ranging from 1 to 198 days, although only four tion of the production of steroid hormones by the subjects had urine collections longer than 20 days. adrenal and gonads. Any alteration in either rate Hydrolysis: During the course of the study, and with the aim of providing more reliable techniques, several of type of hormone production by the glands re- hydrolytic procedures have been used. A short descrip- sulting from specific disease or from hormonal tion of the different methods of hydrolysis follows. therapy therefore must be manifest by qualitative Method A: Stage 1. The urine was adjusted to pH or quantitative change in the excretion of steroid 1 with concentrated sulfuric acid. To this solution, con- hormone metabolites. In order to delineate the centrated sulfuric acid equaling 5 per cent of the original volume was added. The urine was then heated under composition of these metabolites in normal healthy reflux for one-half hour.
    [Show full text]
  • ARCI CLASSIFICATION PROGRAM V14.1
    DRUG TESTING STANDARDS AND PRACTICES PROGRAM. Uniform Classification Guidelines for Foreign Substances And Recommended Penalties Model Rule. January, 2020 (V.14.1) ã ASSOCIATION OF RACING COMMISSIONERS INTERNATIONAL – 2020. Association of Racing Commissioners International 2365 Harrodsburg Road, Suite B-450, Lexington, Kentucky USA 40504 www.arci.com Copywrite 2020, Association of Racing Commissioners International Page 1 of 73 Preamble to the Uniform Classification Guidelines of Foreign Substances The Preamble to the Uniform Classification Guidelines was approved by the RCI Drug Testing and Quality Assurance Program Committee (now the Drug Testing Standards and Practices Program Committee) on August 26, 1991. Minor revisions to the Preamble were made by the Drug Classification subcommittee (now the Veterinary Pharmacologists Subcommittee) on September 3, 1991. "The Uniform Classification Guidelines printed on the following pages are intended to assist stewards, hearing officers and racing commissioners in evaluating the seriousness of alleged violations of medication and prohibited substance rules in racing jurisdictions. Practicing equine veterinarians, state veterinarians, and equine pharmacologists are available and should be consulted to explain the pharmacological effects of the drugs listed in each class prior to any decisions with respect to penalities to be imposed. The ranking of drugs is based on their pharmacology, their ability to influence the outcome of a race, whether or not they have legitimate therapeutic uses in the racing horse, or other evidence that they may be used improperly. These classes of drugs are intended only as guidelines and should be employed only to assist persons adjudicating facts and opinions in understanding the seriousness of the alleged offenses.
    [Show full text]
  • Characterization of Urinary Steroids in Adrenal
    CHARACTERIZATION OF URINARY STEROIDS IN ADRENAL HYPERPLASIA: ISOLATION OF METABOLITES OF CORTISOL, COMPOUND S, AND DESOXYCORTICOSTERONE FROM A NORMOTENSIVE PATIENT WITH ADRENOGENITAL SYNDROME Hortense M. Gandy, … , E. Henry Keutmann, Anthony J. Izzo J Clin Invest. 1960;39(2):364-377. https://doi.org/10.1172/JCI104047. Research Article Find the latest version: https://jci.me/104047/pdf CHARACTERIZATION OF URINARY STEROIDS IN ADRENAL HYPERPLASIA: ISOLATION OF METABOLITES OF CORTI- SOL, COMPOUND S, AND DESOXYCORTICOSTERONE FROM A NORMOTENSIVE PATIENT WITH ADRENOGENITAL SYNDROME * By HORTENSE M. GANDY,t E. HENRY KEUTMANN AND ANTHONY J. IZZO (From the Departmtent of Medicine, the University of Rochester, School of Medicine anld Dentistry, Rochester, N. Y.) (Submitted for publication August 25, 1958; accepted October 8, 1959) Congenital virilizing adrenal hyperplasia miiay corroborated by Bartter and associates (13). present a varied clinical picture. Patients have Dorfman (14) postulated that there is a deficiency been described who have only excessive virilization in the C-21 hydroxylation mechanism. Eberlein (1); others have an associated Addison-like elec- and Bongiovanni (15) then found that some pa- trolyte disturbance (2, 3), with hypoglycemia (4), tients with congenital virilizing adrenal hyper- or with hypertension (5-9). Recent studies (10- plasia excreted C-21 hydroxylated compounds in 12) indicate that the manifestation of virilism may approximately the same quantities as did normal result from defects in the biosynthesis of cortisol.' individuals. Tetrahydrocortisone in small amounts The first suggestion regarding the nature of the was found. The present authors (16) have stud- error was made by Lewis and Wilkins (12), and ied six patients with virilizing adrenal hyperplasia in addition to the one reported here.
    [Show full text]
  • Derwent World Patents Index
    DERWENT WORLD PATENTS INDEX Title Terms © 2000 Thomson. All rights reserved Revised Edition 4 ISBN: 0 901157 23 6 ©© 2000 Thomson Published by Thomson Scientific 14 Great Queen Street, London WC2B 5DF, United Kingdom Visit the Thomson Scientific web site at http://www.thomsonscientific© 2000 Thomson Derwent Published by Derwent Information 14 Great Queen Street, London WC2B 5DF, United Kingdom Visit the Derwent web site at http://www.derwent.com/ Revised Edition 4 published February 2000 ISBN: 0 901157 23 6 (Edition 4 revised) All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means – electronic, mechanical, recording, photocopying or otherwise – without express written permission from the copyright owner.com/ Derwent Title Terms Contents Contents Introduction . 1 Alphabetical List of Title Terms . 5 Derwent Title Terms 1 Introduction DERWENT TITLE TERMS Searchable Preferred Forms of Title Words Introduction Derwent Title Terms are used to simplify word searching of Derwent titles, and to optimise the thoroughness of such searches. All given derivatives of a Title Term are collected under a MAIN TERM. The derivatives are called Sub-terms. Whenever either a MAIN TERM or a Sub-term appears in a Derwent title, only the corre- sponding MAIN TERM is posted to the online file as a Title Term. Example: Searching the Title Term for DESALINATE will capture all records in which desalinate or any of the ten Sub-terms appears in a Derwent title. DESALINATE ¬ MAIN TERM Desalinated Desalinating Desalination Desalinator Desalinators ¬ Sub-terms Desalt Desalted Desalter Desalters Desalting Searching Title Words Both MAIN TERMS and Sub-terms can be searched as Title Words.
    [Show full text]
  • Agency Solicitation Package
    Solicitation Cover Page 1. Solicitation #: 3530000015 2. Solicitation Issue Date: 01/13/2020 3. Brief Description of Requirement: The Office of Management and Enterprise Services, on behalf of the Oklahoma Horse Racing Commission, is accepting proposals for Equine Drug Testing. Solicitation Notice: Please note that on a Request for Proposal (RFP), no pricing shall be released at the time of the opening. Should a public opening be requested, the only information to be released will be a list of bidders without pricing. All questions regarding this solicitation must be submitted in writing and are to be emailed no later than January 27, 2020 at 3:00 PM CST. Questions are to be emailed to [email protected]. Questions received after this date will not be answered. If questions are received, an amendment to this solicitation will be posted on our website listing all questions and answers. 1 4. Response Due Date : February 12, 2020 Time: 3:00 PM CST/CDT 5. Issued By and RETURN SEALED BID TO2: U.S. Postal Delivery Address: 5005 N. Lincoln Blvd. Ste. 300 Oklahoma City, OK 73105 Common Carrier Delivery Address: 5005 N. Lincoln Blvd. Ste. 300 Oklahoma City, OK 73105 Electronic Submission Address: N/A 6. Solicitation Type (type “X” at one below): Invitation to Bid Request for Proposal Request for Quote 7. Contracting Officer: Name: Stephanie Beshears Phone: 405-522-1037 Email: [email protected] 1 Amendments to solicitation may change the Response Due Date (read GENERAL PROVISIONS, section 3, “Solicitation Amendments”) 2 If “U.S. Postal Delivery” differs from “Carrier Delivery, use “Carrier Delivery” for courier or personal deliveries OMES FORM CP 070 – Purchasing | Rev.
    [Show full text]